SPISANI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 9.477
AS - Asia 4.234
EU - Europa 2.467
SA - Sud America 762
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 17.025
Nazione #
US - Stati Uniti d'America 9.283
SG - Singapore 1.721
CN - Cina 1.286
BR - Brasile 642
UA - Ucraina 598
DE - Germania 579
HK - Hong Kong 389
TR - Turchia 326
GB - Regno Unito 312
VN - Vietnam 275
IT - Italia 240
FI - Finlandia 220
SE - Svezia 157
RU - Federazione Russa 122
MX - Messico 100
CA - Canada 78
FR - Francia 74
IN - India 57
PL - Polonia 49
AR - Argentina 47
ZA - Sudafrica 45
BD - Bangladesh 34
ES - Italia 25
JP - Giappone 24
BE - Belgio 23
ID - Indonesia 23
NL - Olanda 21
IQ - Iraq 18
LT - Lituania 16
EC - Ecuador 15
CL - Cile 13
PK - Pakistan 12
CO - Colombia 11
VE - Venezuela 11
IR - Iran 10
PE - Perù 10
KE - Kenya 8
CZ - Repubblica Ceca 7
IL - Israele 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
OM - Oman 5
CH - Svizzera 4
EG - Egitto 4
EU - Europa 4
MA - Marocco 4
AT - Austria 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
PH - Filippine 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
KR - Corea 2
MK - Macedonia 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GI - Gibilterra 1
GT - Guatemala 1
IE - Irlanda 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
SN - Senegal 1
TG - Togo 1
Totale 17.023
Città #
Singapore 976
Woodbridge 962
Fairfield 941
Ashburn 884
Houston 664
Jacksonville 623
Chandler 536
Ann Arbor 485
Santa Clara 445
Beijing 438
Hong Kong 387
Seattle 362
Wilmington 354
Dallas 310
Cambridge 285
Izmir 196
Munich 190
Nanjing 184
Los Angeles 163
New York 153
Princeton 125
San Diego 94
Boardman 88
Ho Chi Minh City 85
Milan 82
São Paulo 78
Buffalo 74
Mexico City 73
Helsinki 71
Shanghai 68
Bremen 61
Ferrara 58
Hanoi 58
Nanchang 53
Hefei 52
Shenyang 48
London 45
Tianjin 42
Warsaw 42
Hebei 41
Montreal 41
Addison 37
Changsha 35
Dong Ket 33
Orem 32
Denver 30
San Mateo 30
Chicago 28
Jinan 28
Turku 28
Brooklyn 26
Chennai 26
Stockholm 26
Johannesburg 25
Atlanta 24
Tokyo 23
Auburn Hills 22
Mountain View 22
Poplar 22
The Dalles 21
Brussels 20
Jiaxing 20
Toronto 20
Phoenix 18
Verona 17
Moscow 16
Kunming 15
Philadelphia 15
Rio de Janeiro 15
Ankara 14
Boston 14
Zhengzhou 14
Augusta 13
Dearborn 13
Falkenstein 13
Frankfurt am Main 13
Tappahannock 13
Haiphong 12
Norwalk 12
Redwood City 12
San Francisco 12
Amsterdam 10
Brasília 10
Curitiba 10
Manchester 10
Ningbo 10
Porto Alegre 10
Belo Horizonte 9
Biên Hòa 9
Charlotte 9
Da Nang 9
Guangzhou 9
Jakarta 9
Taizhou 9
Dhaka 8
Falls Church 8
Goiânia 8
Hải Dương 8
Indiana 8
Leawood 8
Totale 11.917
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 352
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 319
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 292
A cyclic peptide T analogue with high chemotactic activity 263
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 233
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 200
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 198
6-(hydroxyphenyl)imidazo[2,1-b]thiazoles as potential antiinflammatory agents: Effects on human neutrophil functions 198
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 196
Modulation of neutrophil functions by activated platelet release factors 191
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 191
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. 189
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis 187
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 185
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 182
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 182
Ring-opened analogs of indomethacin affecting human neutrophil functions 181
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For‐Hse(Me)‐Leu‐Phe‐OMe 179
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 178
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 177
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 175
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 173
Conformational Aspects of Human Formyl-peptide Receptor Agonists 170
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 170
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 169
Attivita' tumoricida dei neutrofili 168
Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues 167
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 163
Modified chemotactic peptides: Synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe 160
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 159
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 159
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 159
Conformational aspects of human formylpeptide receptor antagonists 159
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 158
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 158
b-peptido sulfonamides. For-Met-Leu-Phe-OMe analogues containing taurine and chiral b-amino-ethansulfonic acid residues 157
Differences arising in human neutrophil activation passing from N-formyl to N-acetyl-oligopeptides 156
An exhaustive insight into the pocket charge features of the methionine receptor using fMLP analogs. 155
Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety 155
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 155
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 155
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 153
An exhaustive insight into the pocket cherge features of the methionine receptor using fMLP analogs. 147
Oligomeric formylpeptide activity on human neutrophils 146
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 146
Probing structural requirements of fMLP receptor: On the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide 146
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 144
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe 143
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 141
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 141
Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue 140
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms 140
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 139
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 139
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 139
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 138
HLA B51 antigen associated with neutrophil hyper-reactivity 138
N-Benzyl-2-chloroindole-3-carboxylic acids as potential anti-inflammatory agents. Synthesis and screening for the effects on human neutrophil functions and on COX1/COX2 activity 138
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 137
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T 136
Synthesis and properties of chemotactic peptide analogs: II. HCO‐Met‐Leu‐Phe‐OMe analogs containing cyclic α,α‐disubstituted amino acids as Met and Phe mimicking residues 134
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 134
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'(methylthio) ethyl] methionine residue 134
Protein kinase C mediates human neutrophil cytotoxicity 132
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 132
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity 132
Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs 132
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 130
Synthesis and bioactivity of chemotactic tetrapeptides: FMLF-OMe analogues incorporating spacer aminoacids at the lateral positions 129
The importance of the methionine configuration in for-Met-Leu-Phe-OMe biological activities. 129
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 129
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 129
2-phenyl-1-arylcarbamoyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 129
Conformation-activity relationship of peptide t and new pseudocyclic hexapeptide analogs 127
alfa-Peptide/beta-sulfonamidopeptide hybrids: analogues of the chemotactic agent For-Met-Leu-Phe-OMe; 127
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 127
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 126
Pseudopeptides containing the 2-hydrazonoacyl fragment: Analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe 121
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 121
Exploring the interest of 1,2-Dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative 117
Antibody-independent cytoxicity against human erythroleukemic K 562 human cells by neutrophils 115
Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16 110
Valutazione funzionale dei leucociti. 110
FLOW CYTOMETRY STUDY OF CR1, CR3 AND GRANULE CONSTITUENTS IN NEUTROPHILS OF MDS PATIENTS AND HEALTHY CONTROLS: RELATIONSHIP WITH FUNCTIONAL ACTIVITIES AND DISEASE STATES 107
NEW CHEMOTACTIC PEPTIDE ANALOGS WITH HIGH BIOLOGICAL ACTIVITY FOR HUMAN NEUTROPHILS 105
Effects of Synthetic Peptides on the Inflammatory Response and Their Therapeutic Potential. 103
Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells 102
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 101
Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: The N-terminal region 100
Chemotactic effects of nociceptin/orphanin FQ on human monocytes are mediated by nop receptor activation 100
Peptide T revisited: Conformational mimicry of epitopes of anti-HIV proteins 98
null 96
NEUTROPHILS FROM PATIENTS WITH MYELODISPLASTIC SYNDROMES: RELATIONSHIP BETWEEN IMPAIRMENT OF GRANULAR CONTENTS, COMPLEMENT RECEPTORS, FUNCTIONAL ACTIVITIES AND DISEASE STATUS 95
Met-Ile-Phe-Leu derivates: full and partial agonist towards formyl peptide receptors of human neutrophils. 95
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. J.Pept.Sci, 18, 418-426, 2012. 94
Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+ 92
null 92
null 92
Selective interaction of myelin basic protein and monoclonal antibody with leukocyte membrane 90
null 90
Totale 14.922
Categoria #
all - tutte 76.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.038
Totale 77.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021836 0 0 0 0 0 147 54 165 22 160 196 92
2021/20221.290 40 162 102 89 61 35 54 64 37 83 144 419
2022/20231.270 132 61 52 153 224 199 62 112 170 7 53 45
2023/2024517 69 66 31 14 27 106 23 51 9 3 4 114
2024/20252.531 67 30 183 72 349 253 138 154 407 274 343 261
2025/20264.525 763 553 704 1.062 1.069 374 0 0 0 0 0 0
Totale 17.131